Drug Candidate Slows Age-related Macular Degeneration

Research results show that the progression of age-related macular degeneration is markedly slowed in new laboratory-engineered mice when they received treatments of retinylamine, a trial drug that has been tested in a medical school lab. AMD is a leading cause of vision loss in Americans 60 years of age and older.

Read the whole article on Science Daily

More from Science Daily